Why Licensed UK Pharmacy Supply Matters for Weight Management
GPhC Registered Pharmacy: Your Wegovy vs Mounjaro Treatment Foundation
When comparing Wegovy vs Mounjaro options, choosing a properly regulated UK pharmacy becomes as important as the medication itself. EverydayMeds operates under GPhC registration #9012878, meaning every aspect of our service undergoes regular inspection and audit by the General Pharmaceutical Council. Our Leicester-based facility maintains full MHRA compliance for prescription-only medicine supply, ensuring your Wegovy or Mounjaro treatment meets the same standards as high-street pharmacies. Licensed UK prescribers review every consultation, whether you're considering the GLP-1 approach of Wegovy or the dual GIP+GLP-1 mechanism of Mounjaro.
The regulatory framework protecting your treatment extends beyond basic pharmacy registration. Our prescribers hold valid GMC registration and complete ongoing training in obesity medicine, ensuring they can properly assess your suitability for either Wegovy or Mounjaro based on current NICE guidelines. This clinical oversight proves essential when navigating the Wegovy vs Mounjaro decision, as both medications require careful consideration of your medical history, current medications, and treatment goals alongside a reduced-calorie diet and increased physical activity.
Wegovy vs Mounjaro Pricing: Complete UK Cost Breakdown
Understanding the complete cost structure helps inform your Wegovy vs Mounjaro decision from a practical perspective. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with FIRST40 code for new customers), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers use discount code FIRST40 at checkout, whilst returning customers apply code DOSE25 to reach these final prices. Our bundle options provide supply convenience, such as the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99, supporting your complete dose escalation journey.
Mounjaro pricing follows a different structure reflecting its dual-hormone approach, though both medications require the same clinical assessment and prescriber review process. The 3-minute online consultation leads to standard prescriber review within 3 working days, or express 24-hour review for urgent needs. Next-day delivery via temperature-controlled courier ensures medication integrity whether you choose Wegovy's GLP-1 approach or Mounjaro's combined mechanism, with all costs transparent before you complete your order.
Clinical Evidence Behind the Wegovy vs Mounjaro Comparison
The STEP clinical trial programme demonstrated Wegovy's effectiveness in weight management alongside lifestyle modifications. In STEP 1, participants using Wegovy experienced an average weight reduction of approximately 15% at 68 weeks compared to 2.4% with placebo, whilst STEP 2 showed around 9.6% average weight loss in patients with type 2 diabetes (Wilding et al., NEJM, 2021). These results occurred alongside reduced-calorie diet and increased physical activity programmes.
Mounjaro's clinical evidence comes from the SURMOUNT trials, utilising a different study design and participant population, making direct comparison inappropriate. Both medications represent prescription-only approaches requiring individual clinical assessment to determine suitability. Your prescriber can review both options during consultation, considering your specific circumstances when weighing the Wegovy vs Mounjaro decision for your treatment plan.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone. This mechanism works on brain appetite centres to reduce hunger signals whilst promoting feelings of fullness after smaller meals. The once-weekly injection delivered via FlexTouch pen provides consistent medication levels, supporting appetite control throughout the week. Many patients report reduced food cravings and earlier satiety when eating, though individual responses vary considerably. The treatment requires commitment to dietary changes and increased physical activity to achieve optimal results, as the medication enhances rather than replaces lifestyle modifications.
Your Wegovy vs Mounjaro Ordering Process
Starting treatment through our GPhC registered pharmacy begins with a comprehensive 3-minute clinical assessment covering your medical history, current medications, and treatment goals. Licensed UK prescribers review every consultation within 3 working days (or 24 hours with express service), ensuring clinical safety whether you're considering Wegovy or Mounjaro. Once approved, next-day delivery via temperature-controlled courier maintains medication integrity from our Leicester facility to your door. The entire process maintains full audit trail compliance with MHRA regulations, providing the same clinical oversight as traditional pharmacy consultations. Your prescriber may recommend starting with specific doses based on your individual circumstances and any previous weight management experience.
Storage and Practical Considerations: Wegovy vs Mounjaro
Wegovy requires refrigerated storage at 2-8°C before first use, with a significant practical advantage of remaining stable for up to 6 weeks at room temperature below 30°C once removed from the fridge. This storage flexibility exceeds Mounjaro's 21-day room temperature limit, making Wegovy more convenient for travel or varied schedules. The FlexTouch pen delivery system provides pre-measured doses with clear visual confirmation of injection completion. Dose escalation follows a strict schedule starting at 0.25mg for weeks 1-4, progressing through 0.5mg, 1mg, 1.7mg, to reach 2.4mg maintenance dosing. Each dose level allows your body to gradually adapt whilst monitoring for side effects, ensuring optimal tolerance throughout your treatment journey.
Regulatory Compliance: Why GPhC Registration Matters for Wegovy vs Mounjaro
The weight management medication market includes many unregulated suppliers, making GPhC registration essential for patient safety. Our pharmacy registration #9012878 ensures full traceability from manufacturer to patient, with every Wegovy and Mounjaro supply batch recorded and auditable by regulatory authorities. This compliance extends to prescriber qualifications, with all clinical staff maintaining current GMC registration and obesity medicine training. MHRA additional monitoring applies to both medications, requiring enhanced pharmacovigilance and side effect reporting.
Licensed supply chains prevent counterfeit medications entering your treatment, whilst regulated prescriber oversight ensures appropriate clinical monitoring throughout your journey. When comparing Wegovy vs Mounjaro options online, verifying pharmacy registration through pharmacyregulation.org provides essential protection against unlicensed suppliers who may compromise medication quality or clinical safety standards.
Making Your Wegovy vs Mounjaro Decision with Clinical Support
Both Wegovy and Mounjaro are available from EverydayMeds, with your prescriber helping determine which approach suits your individual circumstances best. The consultation process considers your medical history, previous weight management attempts, lifestyle factors, and treatment preferences when recommending either option. Clinical assessment remains essential for both medications, as prescription-only medicine regulations require individual evaluation rather than self-selection. Starting your consultation today with discount codes FIRST40 (new customers) or DOSE25 (returning customers) begins your medically supervised weight management journey with full regulatory protection and clinical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
